Drug Interaction Between Doxycycline and Amoxicillin-Clavulanic Acid
There is no clinically significant drug interaction between doxycycline and amoxicillin-clavulanic acid, and these antibiotics can be safely co-administered when clinically indicated.
Evidence from Guidelines and Clinical Practice
Multiple high-quality guidelines explicitly recommend using doxycycline and amoxicillin-clavulanic acid together or as interchangeable alternatives for various infections, which would not occur if there were concerning interactions:
Documented Co-Administration in Guidelines
The British Thoracic Society (2019) guidelines for bronchiectasis list both amoxicillin-clavulanic acid and doxycycline as treatment options for the same pathogens, including as second-line alternatives for Haemophilus influenzae (beta-lactamase positive) and Staphylococcus aureus (MRSA) 1. This interchangeability demonstrates no contraindication to their combined use.
The IDSA guidelines (2014) for skin and soft tissue infections recommend both agents for various conditions, including animal bites where amoxicillin-clavulanic acid is first-line oral therapy, with doxycycline listed as an alternative or adjunctive option 2, 3. For human bites specifically, doxycycline is recommended with good activity against Eikenella species, staphylococci, and anaerobes 3.
The WHO Essential Medicines guidelines (2024) list both antibiotics across multiple infection categories without any warnings about concurrent use 4.
Clinical Research Supporting Safety
Research studies have directly evaluated these antibiotics in combination:
A 1995 study specifically compared ofloxacin + amoxicillin-clavulanic acid versus doxycycline + amoxicillin-clavulanic acid for pelvic Chlamydia trachomatis infections, demonstrating that the doxycycline-amoxicillin-clavulanic acid combination was both safe and effective (96.6% clinical success, 98.4% bacteriological success) 5.
Multiple comparative studies have evaluated these antibiotics as alternatives without identifying interaction concerns 6, 7, 8.
Mechanism and Pharmacology
From the FDA drug label, amoxicillin-clavulanic acid has documented interactions with probenecid (increases amoxicillin levels) and allopurinol (increases rash incidence), and may reduce oral contraceptive efficacy 9. Doxycycline is not mentioned as an interacting drug in the official labeling.
Both antibiotics work through different mechanisms:
- Amoxicillin-clavulanic acid: Beta-lactam that inhibits bacterial cell wall synthesis
- Doxycycline: Tetracycline that inhibits bacterial protein synthesis
These distinct mechanisms mean they do not compete for the same targets or metabolic pathways.
Clinical Considerations
When Co-Administration May Be Appropriate
- Polymicrobial infections requiring broad-spectrum coverage (e.g., severe animal or human bites, intra-abdominal infections)
- Treatment failures where sequential therapy is needed
- Atypical pathogen coverage where doxycycline adds value to beta-lactam therapy
Important Caveats
- Avoid doxycycline in children <8 years due to tooth discoloration risk 10, 11
- Avoid doxycycline in pregnancy/lactation 10
- Monitor for additive gastrointestinal effects as both can cause GI upset, though amoxicillin-clavulanic acid has higher rates 9, 6
- Consider photosensitivity with doxycycline during summer months 10
Practical Guidance
If prescribing both antibiotics:
- Take amoxicillin-clavulanic acid with food to reduce GI upset 9
- Take doxycycline with 8 ounces of fluid and food 10
- Space doses appropriately based on individual regimens
- Monitor for diarrhea, which if severe or persistent >2-3 days warrants evaluation for C. difficile 9
The absence of any interaction warnings in major guidelines, FDA labeling, and the documented safe use in clinical trials confirms these antibiotics can be used together when clinically appropriate.